Comparison of Hybrid LCMS & Ligand Binding Assays for Bioanalysis, Upcoming Webinar Hosted by Xtalks
Retrieved on:
Monday, April 5, 2021
TORONTO, April 5, 2021 /PRNewswire-PRWeb/ -- Historically, bioanalytical support for large molecule development has utilized ligand binding (LBA) technologies.
Key Points:
- TORONTO, April 5, 2021 /PRNewswire-PRWeb/ -- Historically, bioanalytical support for large molecule development has utilized ligand binding (LBA) technologies.
- Hybrid mass spectrometry only requires one reagent for enrichment and this reagent does not need to be extremely selective.
- In the past, our ligand binding team provided the majority of our large molecule bioanalysis support.
- For more information, or to register for this event, visit Comparison of Hybrid LCMS & Ligand Binding Assays for Bioanalysis.